Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Accepts healthy volunteers Results available

Selenium for Prevention of Adenomatous Colorectal Polyps

ClinicalTrials.gov ID: NCT00078897

Public ClinicalTrials.gov record NCT00078897. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Selenium may be effective in preventing the recurrence of adenomatous colorectal polyps. PURPOSE: This randomized phase III trial is studying selenium to see how well it works in preventing the recurrence of polyps in patients with adenomatous colorectal polyps.

Study identification

NCT ID
NCT00078897
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of Arizona
Other
Enrollment
1,621 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 20, 2005 (Actual)
Primary completion
Jan 7, 2014 (Actual)
Completion
May 17, 2018 (Actual)
Last update posted
Sep 24, 2019

2005 – 2018

United States locations

U.S. sites
7
U.S. states
4
U.S. cities
6
Facility City State ZIP Site status
Veterans Affairs Medical Center - Phoenix Phoenix Arizona 85012 —
Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea Scottsdale Arizona 85258-4512 —
Mayo Clinic Scottsdale Scottsdale Arizona 85259-5499 —
Arizona Cancer Center - Tucson Clinic Tucson Arizona 85724-5024 —
University of Colorado Cancer Center at UC Health Sciences Center Denver Colorado 80220 —
Endoscopy Center of Western New York Williamsville New York 14221 —
Baylor University Medical Center - Dallas Dallas Texas 75246 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00078897, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2019 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00078897 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →